Patent details

Basic Information

Publication number:

EP2459216

PCT Application Number:

PCT/IB/2010/002386

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP107663320

PCT Publication Number:

WO/2011/027222

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

IMMUNOGENIC COMPOSITIONS INCLUDING TLR ACTIVITY MODULATORS

French Title of Invention:

COMPOSITIONS IMMUNOGÈNES COMPRENANT DES MODULATEURS DE L'ACTIVITÉ TLR

German Title of Invention:

IMMUNOGENE ZUSAMMENSETZUNGEN MIT TLR-AKTIVITÄTSMODULATOREN

SPC Number:

Dates

Filing date:

01/09/2010

Grant date:

30/10/2013

EP Publication Date:

30/10/2013

PCT Publication Date:

10/03/2011

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

06/06/2012

EP B1 Publication Date:

30/10/2013

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

01/09/2030

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

08/05/2017

 

 

Name:

GlaxoSmithKline Biologicals SA

Address:

Rue de l'Institut, 89, 1330 Rixensart, Belgium (BE)

History of Owners

From:

01/09/2010

To:

08/05/2017

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Agent

1

Name:

KIRKPATRICK

From:

02/05/2018

Address:

AVENUE WOLFERS 32, 1310, LA HULPE, Belgium (BE)

To:

2

Name:

OFFICE FREYLINGER S.A.

From:

06/11/2013

Address:

PO Box 48, 8001, STRASSEN, Luxembourg (LU)

To:

02/05/2018

Inventor

1

Name:

DORO Francesco

Address:

Italy (IT)

2

Name:

CIANETTI Simona

Address:

Italy (IT)

3

Name:

JAIN Siddhartha

Address:

United States (US)

4

Name:

O'HAGAN Derek, Thomas

Address:

United States (US)

5

Name:

SINGH Manmohan

Address:

United States (US)

6

Name:

SKIBINSKI David

Address:

Italy (IT)

Priority

Priority Number:

239156 P

Priority Date:

02/09/2009

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 39/095;

Publication

Bulletin

Bulletin Heading:

CO

Bulletin edition number:

2017/03

Publication date:

21/07/2017

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of ownership

Deed Number:

RC20170000137A

Date Registered:

08/05/2017

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

MARKS & CLERK LLP

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

GlaxoSmithKline Biologicals SA

Address:

Rue de l'Institut, 89, 1330 Rixensart, Belgium (BE)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

30/09/2025

Annual Fee Number:

16

Annual Fee Amount:

230 Euro

Expected Payer:

Last Annual Fee Payment Date:

20/08/2024

Last Annual Fee Paid Number:

15

Last Annual Fee Paid Amount:

213 Euro

Payer:

ANAQUA SERVICES (ANC. SGA2)

Filing date	Document type	Number of pages
09/05/2017	Outgoing Correspondence	1
02/05/2018	Request For Change	2
02/05/2018	Outgoing Correspondence	1
08/05/2017	Request For Change	11